Lazard Healthcare Services Leaders Study 2025

Healthcare services companies confronted significant macroeconomic and policy uncertainty in late 2024 and into 2025. The uncertainty roiled markets and rendered it challenging for Boards and business leaders to make critical decisions. Tariff announcements, with unclear scope, level, and duration, intensified market volatility and raised concerns about inflation, growth, and cross-border business activities. Against this backdrop we fielded this year’s Healthcare Services Leaders Study in February 2025.

This year’s study included participation from 187 leaders across many of the largest healthcare services companies as well as small and mid-sized private companies and prominent investment firms. The study examines their perspectives on capital markets, strategic priorities, industry and regulatory outlook, applications of artificial intelligence, and other key themes shaping the industry.